Sensor Approach for Brain Pathophysiology of Freezing of Gait in Parkinson\u27s Disease Patients

Parkinson\u27s Disease (PD) affects over 1% of the population over 60 years of age and is expected to reach 1 million in the USA by the year 2020, growing by 60 thousand each year. It is well understood that PD is characterized by dopaminergic loss, leading to decreased executive function causing motor symptoms such as tremors, bradykinesia, dyskinesia, and freezing of gait (FoG) as well as non-motor symptoms such as loss of smell, depression, and sleep abnormalities. A PD diagnosis is difficult to make since there is no worldwide approved test and difficult to manage since its manifestations are widely heterogeneous among subjects. Thus, understanding the patient subsets and the neural biomarkers that set them apart will lead to improved personalized care. To explore the physiological alternations caused by PD on neurological pathways and their effect on motor control, it is necessary to detect the neural activity and its dissociation with healthy physiological function. To this effect, this study presents a custom ultra-wearable sensor solution, consisting of electroencephalograph, electromyograph, ground reaction force, and symptom measurement sensors for the exploration of neural biomarkers during active gait paradigms. Additionally, this study employed novel de-noising techniques for dealing with the motion artifacts associated with active gait EEG recordings and compared time-frequency features between a group of PD with FoG and a group of age-matched controls and found significant differences between several EEG frequency bands during start and end of normal walking (with a p\u3c0.05)

Identification of audio evoked response potentials in ambulatory EEG data

Electroencephalography (EEG) is commonly used for observing brain function over a period of time. It employs a set of invasive electrodes on the scalp to measure the electrical activity of the brain. EEG is mainly used by researchers and clinicians to study the brain’s responses to a specific stimulus - the event-related potentials (ERPs). Different types of undesirable signals, which are known as artefacts, contaminate the EEG signal. EEG and ERP signals are very small (in the order of microvolts); they are often obscured by artefacts with much larger amplitudes in the order of millivolts. This greatly increases the difficulty of interpreting EEG and ERP signals.Typically, ERPs are observed by averaging EEG measurements made with many repetitions of the stimulus. The average may require many tens of repetitions before the ERP signal can be observed with any confidence. This greatly limits the study and useof ERPs. This project explores more sophisticated methods of ERP estimation from measured EEGs. An Optimal Weighted Mean (OWM) method is developed that forms a weighted average to maximise the signal to noise ratio in the mean. This is developedfurther into a Bayesian Optimal Combining (BOC) method where the information in repetitions of ERP measures is combined to provide a sequence of ERP estimations with monotonically decreasing uncertainty. A Principal Component Analysis (PCA) isperformed to identify the basis of signals that explains the greatest amount of ERP variation. Projecting measured EEG signals onto this basis greatly reduces the noise in measured ERPs. The PCA filtering can be followed by OWM or BOC. Finally, crosschannel information can be used. The ERP signal is measured on many electrodes simultaneously and an improved estimate can be formed by combining electrode measurements. A MAP estimate, phrased in terms of Kalman Filtering, is developed using all electrode measurements.The methods developed in this project have been evaluated using both synthetic and measured EEG data. A synthetic, multi-channel ERP simulator has been developed specifically for this project.Numerical experiments on synthetic ERP data showed that Bayesian Optimal Combining of trial data filtered using a combination of PCA projection and Kalman Filtering, yielded the best estimates of the underlying ERP signal. This method has been applied to subsets of real Ambulatory Electroencephalography (AEEG) data, recorded while participants performed a range of activities in different environments. From this analysis, the number of trials that need to be collected to observe the P300 amplitude and delay has been calculated for a range of scenarios